GENE ONLINE|News &
Nearly 50 Cell and Gene Therapies Benefit From New FDA Flexibility
FDA updates flexible requirements for cell and gene therapies, supporting innovation while maintaining safety and regulatory standards.
Cell and gene therapies are a new class of medicines that use living cells or genetic material to treat serious diseases, often targeting rare genetic disorders, blood cancers, and certain immune system conditions. Most of these therapies have only been developed and approved in the last ten years, making them a rapidly evolving part of … Nearly 50 Cell and Gene Therapies Benefit From New FDA Flexibility Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
